Perry Robins, MD, is Professor Emeritus of Dermatology at the New York University School of Medicine. Dr. Robins has practiced medicine for over 40 years and has treated more than 47,000 skin cancer patients. Over 40% of the doctors who specialize in skin cancer were either trained by Dr. Robins himself or by doctors he has trained. He has lectured in 37 countries in 4 languages. At present, he performs more than 500 procedures annually and conducts training workshops for his peers on advanced techniques of dermatologic surgery. Dr. Robins is the founder and President of The Skin Cancer Foundation, a national organization dedicated to the research of skin cancer and public and medical education. Dr. Robins is also the founder/president of the International Society of Dermatologic Surgeons, founder/former-president of the Mohs Society, and former-president of the American Society of Dermatologic Surgery.

Board-certified dermatologist, Deborah S. Sarnoff MD, is one of the country's premier specialists in Mohs surgery for the treatment of skin cancer, cosmetic dermatology, and laser surgery. Dr. Sarnoff graduated from the George Washington University School of Medicine with distinction and received her residency and fellowship training in Mohs surgery and dermatologic surgery at New York University, under the direction of Dr. Perry Robins.Currently, Dr. Sarnoff is a Clinical Professor of Dermatology at NYU School of Medicine, President of The Skin Cancer Foundation, President of the International Society for Dermatologic Surgery and Secretary/Treasurer of The NYS Society of Dermatology and Dermatologic Surgery. Dr. Sarnoff is also Director of Dermatologic Surgery at Cosmetique Dermatology, Laser & Plastic Surgery, located in New York City.

Macrene Alexiades MD PhD Robert Baran MD Joseph B. Bikowski MD Dee Anna Glaser MD C. William Hanke MD William Levis MD Ronald L. Moy MD Keyvan Nouri MD Neil S. Sadick MD Gerhard Sattler MD James M. Spencer MD Susan H. Weinkle MD

Senior Associate Editors

Kenneth Beer MD Martin Braun MD Jeffrey Phillip Callen MD Jean Carruthers MD James Q. Del Rosso DO Lawrence F. Eichenfield MD Patricia Farris MD Norman Goldstein MD Aditya K. Gupta MD PhD Elizabeth Hale MD Sherry H. Hsiung MD Leon Kircik MD Mark Lebwohl MD Henry W. Lim MD Flor Mayoral MD Maurizio Podda MD PhD Jeffrey Orringer MD Maritza Perez MD Kevin Pinski MD Luigi Rusciani Scorza MD Ritu Saini MD Jerome l. Shupack MD Amy Taub MD Danny Vleggaar MD Brian Zelickson MD

Kendra G. Bergstrom MD Joel L. Cohen MD Adam Friedman MD James L. Griffith MD Marissa Heller MD Isaac Zilinsky MD

Past Co-Editors-In-Chief

Elizabeth Hale MD (2004) Susan H. Weinkle MD (2005-2008) Keyvan Nouri MD (2005-2008) Sherry H. Hsiung MD (2008) James M. Spencer MD (2009-2013)

About Us - JDDonline - Journal of Drugs in Dermatology

About Us

The Journal of Drugs in Dermatology (JDD) is a peer-reviewed publication indexed with MEDLINE®/PubMed® that was founded by the renowned Dr. Perry Robins MD. Founded in 2002, it offers one of the fastest routes to disseminate dermatologic information and is considered the fastest growing publication in dermatology.

We present original articles, award-winning case reports, and timely features pertaining to new methods, techniques, drug therapy, and devices in dermatology that provide readers with peer reviewed content of the utmost quality.

Our high standards of content are maintained through a balanced, peer-review process. Articles are reviewed by an International Editorial Board of over 160 renowned experts.

JDD reaches around 13,760 dermatology healthcare professionals and has been recognized as the official partner of the Skin of Color Update (SOCU) and the ODAC Dermatology Aesthetic and Surgical (ODAC) conferences.

The extremely current and practical editorial content of JDD results in high readership and maximum exposure among the dermatology community.

Our Mission is Excellence through Peer Review: To educate physicians, optimize patient outcomes, and disseminate key scientific information.

JDD is published by SanovaWorks.

In the News

September 22, 2025 in Atopic Dermatitis, Featured Articles, JDD Highlights, JDD in the Media, The Latest

JDD in the News: Pharmacy Deserts and Affordability Concerns in Atopic Dermatitis Care

Healio profiled a July Journal of Drugs in Dermatology study on the affordability of dermatologist-recommended skincare products for atopic dermatitis. The study, “Socioeconomic Disparities in Gentle Skin Care Access for…

August 18, 2025 in Featured Articles, JDD Highlights, JDD in the Media, Skincare, The Latest

JDD in the News: Perceived Dermatologic Side Effects of Cancer Treatments

Several media outlets covered an August Journal of Drugs in Dermatology survey on the perceived dermatologic side effects of cancer treatments and how those perceptions could impact a person’s decision…

June 23, 2025 in JDD Highlights, JDD in the Media, Skin Cancer, The Latest

Dermatology Roundup: Drug Class Effective Against Treatment-Resistant Melanoma

Researchers at NYU Langone Health and the Perlmutter Cancer Center have discovered why many patients with melanoma are resistant to current treatments and how an existing drug class is effective…

June 20, 2025 in Featured Articles, JDD Highlights, JDD in the Media, Skincare, The Latest

JDD in the News: Proposed Universal Classification System for Topical Corticosteroids

Healio profiled a new universal classification system for topical corticosteroids that could reduce confusion across countries. The system was published in the May Journal of Drugs in Dermatology in an…

May 21, 2025 in Acne, Derm Community, Featured Articles, JDD Highlights, JDD in the Media, The Latest

JDD in the News: Upadacitinib’s Potential Cardiovascular Effects

Upadacitinib may provide additional health benefits, including reducing the risk of major adverse cardiovascular events (MACE) and venous thromboembolism (VTE). That’s according to a May Journal of Drugs in Dermatology…

Editorial Board